1. Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS; ELCAP Group. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol. 2002; 178:1053–1057. PMID:
11959700.
2. Nakata M, Saeki H, Takata I, Segawa Y, Mogami H, Mandai K, et al. Focal ground-glass opacity detected by low-dose helical CT. Chest. 2002; 121:1464–1467. PMID:
12006429.
Article
3. Hasegawa M, Sone S, Takashima S, Li F, Yang ZG, Maruyama Y, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol. 2000; 73:1252–1259. PMID:
11205667.
Article
4. Aoki T, Nakata H, Watanabe H, Nakamura K, Kasai T, Hashimoto H, et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR Am J Roentgenol. 2000; 174:763–768. PMID:
10701622.
5. Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer. 1995; 75:2844–2852. PMID:
7773933.
Article
6. Kodama K, Higashiyama M, Yokouchi H, Takami K, Kuriyama K, Kusunoki Y, et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg. 2002; 73:386–392. PMID:
11845847.
Article
7. Kakinuma R, Ohmatsu H, Kaneko M, Kusumoto M, Yoshida J, Nagai K, et al. Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr. 2004; 28:17–23. PMID:
14716227.
Article
8. Nakajima R, Yokose T, Kakinuma R, Nagai K, Nishiwaki Y, Ochiai A. Localized pure ground-glass opacity on high-resolution CT: histologic characteristics. J Comput Assist Tomogr. 2002; 26:323–329. PMID:
12016356.
Article
9. Takashima S, Sone S, Li F, Maruyama Y, Hasegawa M, Matsushita T, et al. Small solitary pulmonary nodules (< or =1 cm) detected at population-based CT screening for lung cancer: Reliable high-resolution CT features of benign lesions. AJR Am J Roentgenol. 2003; 180:955–964. PMID:
12646435.
10. Colby TV, Noguchi M, Henschke C, Vazquez MF, Geiniger K , Yokosa T, et al. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, editors. Adenocarcinoma. World Health Organization classification of tumours: Tumors of the lung, pleura, thymus and heart. 2004. 1st ed. Lyon: IARC Press;p. 35–44.
11. Shimosato Y, Suzuki A, Hashimoto T, Nishiwaki Y, Kodama T, Yoneyama T, et al. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Am J Surg Pathol. 1980; 4:365–373. PMID:
7425202.
Article
12. Miller R. Bronchioloalveolar cell adenomas. Am J Surg Pathol. 1990; 14:904–912. PMID:
2403196.
Article
13. Mori M, Tezuka F, Chiba R, Funae Y, Watanabe M, Nukiwa T, et al. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: their heterology in form and analogy in immunohistochemical characteristics. Cancer. 1996; 77:665–674. PMID:
8616758.
Article
14. Suzuki K, Nagai K, Yoshida J, Yokose T, Kodama T, Takahashi K, et al. The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis. Cancer. 1997; 79:1521–1526. PMID:
9118033.
15. Suzuki K, Takahashi K, Yoshida J, Nishimura M, Yokose T, Nishiwaki Y, et al. Synchronous double primary lung carcinomas associated with multiple atypical adenomatous hyperplasia. Lung Cancer. 1998; 19:131–139. PMID:
9567250.
Article
16. Park CM, Goo JM, Lee HJ, Lee CH, Chung DH, Kim HC, et al. CT findings of atypical adenomatous hyperplasia of the lung. Korean J Radiol. 2006; 7:80–86. PMID:
16799268.
17. Kodama K, Doi O, Higashiyama M, Yokouchi H. Intentional limited resection for selected patients with T1 N0 M0 non-small cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg. 1997; 114:347–353. PMID:
9305186.
18. Pastorino U, Valente M, Bedini V, Infante M, Tavecchio L, Ravasi G. Limited resection for stage 1 lung cancer. Eur J Surg Oncol. 1991; 17:42–46. PMID:
1995356.
19. Nakamura H, Saji H, Ogata A, Saijo T, Okada S, Kato H. Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection. Lung Cancer. 2004; 44:61–68. PMID:
15013584.
Article
20. Watanabe S, Watanabe T, Arai K, Kasai T, Haratake J, Urayama H. Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography. Ann Thorac Surg. 2002; 73:1071–1075. PMID:
11996243.
Article
21. Nakata M, Sawada S, Yamashita M, Saeki H, Kurita A, Takashima S, et al. Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005; 129:1226–1231. PMID:
15942561.
Article
22. Yoshida J, Nagai K, Yokose T, Nishimura M, Kakinuma R, Ohmatsu H, et al. Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg. 2005; 129:991–996. PMID:
15867771.
Article
23. Kim KG, Goo JM, Kim JH, Lee HJ, Min BG, Bae KT, et al. Computer-aided diagnosis of localized ground-glass opacity in the lung at CT: initial experience. Radiology. 2005; 237:657–661. PMID:
16192320.
Article
24. Nagao M, Murase K, Yasuhara Y, Ikezoe J, Eguchi K, Mogami H, et al. Measurement of localized ground-glass attenuation on thin-section computed tomography images: correlation with the progression of bronchioloalveolar carcinoma of the lung. Invest Radiol. 2002; 37:692–697. PMID:
12447003.